Research. Develop. Collaborate. Commercialise | Advanced Therapies 2024

19 - 20 March 2024
ExCel, London

ADVANCING CELL AND GENE THERAPIES

First Look Agenda

Tickets from £195
Offer closes 03 NOVEMBER

EUROPE'S LARGEST CELL & GENE THERAPY EVENT

2,500+

Attendees

300+

Speakers

100+

Exhibitors

100+

Biotech Start-Ups

2

Days

What is the Advanced Therapies Congress?

Conference

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development with 10 tracks of content over 2 days.

SEE LATEST AGENDA

Exhibition

100 leading solution providers to meet your needs across all stages of cell and gene therapy development

SEE EXHIBITOR LIST

Networking

Connect with thousands of cell and gene therapy experts in 12+ hours of built-in 1-2-1 networking

GET YOUR TICKET NOW

Covering the entire pipeline of ATMPs

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.

Get your ticket now
From £195 offer closes 03 November

Europe’s largest commercial cell and gene therapy conference

Evidence, Pricing & Access

Ensuring clinical success
Tackling large scale regulatory challenges
Finding the right framework for reimbursement and market access
Cross-border healthcare
Outcome based agreements

Gene Modified Cell Therapy

Autologous vs allogeneic
Tackling solid tumours
Combination therapy
CAR-T, NK, Gamma-Delta cells
Patient stratification and precision medicine approaches

Cell Therapy

Stem cells
Regenerative Medicine
MSCs vs iPSCs
Cord blood advancements

Gene Therapy

Next generation of gene therapy
Moving from rare to more common diseases
Tackling immunogenicity
Rare diseases & orphan drugs
Novel gene delivery systems

Cell Therapy Manufacturing

Automation & closed systems
Scaling up to commercial level
Keeping costs low
In house vs outsourcing

Viral Vector Manufacturing

Continuous manufacturing
Scaling up for commercial production
In house vs outsourcing

Clinical Trials & Development

Ensuring clinical success
Clinical and nursing perspectives
Moving from clinical to commercial

Gene Editing

Latest cutting edge technology
Latest academic research
Safety & ethics

Immunotherapy

Immunotherapy for solid tumours
AI in oncology
Precision medicine

Supply Chain & Logistics

Logistics, transportation, distribution & cold chain
Moving from clinical to commercial
Patient experience
Supply chain
Point of care delivery

Regulation

Tackling large scale regulatory challenges
Patient informed policy decisions

Innovation Showcase

Latest in academic research
Latest cutting-edge technologies success
Tackling large scale regulatory challenges
Finding the right framework for reimbursement and market access
Cross-border healthcare
Outcome based agreements

Start-ups

Company presentations from exciting new start-ups
Investor perspectives

Get your ticket now
From £195 offer closes 03 November

SEE LATEST AGENDA

Our incredible line-up for 2024
Over 300 speakers

Xiaokui Zhang
CSO
Aspen Neuroscience

Xiaokui Zhang speaking at Advanced Therapies Congress

Lior Raviv
CTO
Pluri

Lior Raviv speaking at Advanced Therapies Congress

Angela Columbano
Head of Business Development & Partnership
Genethon

Angela Columbano speaking at Advanced Therapies Congress

Roberto Nitsch
Associate Director
Astra Zeneca

Roberto Nitsch speaking at Advanced Therapies Congress

Shree Patel
EVP Patient Supply Operations
Achilles Therapeutics

Shree Patel speaking at Advanced Therapies Congress

Sven Kili
CEO
Antion Biosciences

Sven Kili speaking at Advanced Therapies Congress

Natalie Ward
Director, Regulatory Affairs CMC
Adaptimmune

Natalie Ward speaking at Advanced Therapies Congress

Vicki Coutinho
VP Regulatory Affairs & Quality
Takeda

Vicki Coutinho speaking at Advanced Therapies Congress

Snehal Naik
Head of Regulatory Policy
Spark Therapeutics

Snehal Naik speaking at Advanced Therapies Congress

Jaap Boelens
Chief Stem Cell Transplantation and Cellular Therapies Paediatrics
Memorial Sloan-Kettering Cancer Center

Jaap Boelens speaking at Advanced Therapies Congress

Janet Glassford
Senior Quality Assessor
MHRA

Janet Glassford speaking at Advanced Therapies Congress

David Morrow
Senior Scientific Program Manager
EATRIS

David Morrow speaking at Advanced Therapies Congress

Angela Justice
Chief People Officer & Head of Medical Affairs
TCR2 Therapeutics

Angela Justice speaking at Advanced Therapies Congress

Owen Smith
Partner
4BIO Capital

Owen Smith speaking at Advanced Therapies Congress

Uta Griesenbach
Professor, Molecular Medicine, National Heart And Lung Institute
Imperial College London

Uta Griesenbach speaking at Advanced Therapies Congress

Amir Hefni
Global Head, Cell & Gene Therapy
Novartis

Amir Hefni speaking at Advanced Therapies Congress

SEE ALL SPEAKERS

Proud to announce our 2024 sponsors and exhibitors

See full exhibitor list

Remaining marketing opportunities for world class solution providers are selling fast.
Contact: ashlea.foster@terrapinn.com

Get the sponsorship
and exhibition brochure

"Very insightful and cutting-edge talks and panel discussions"

– Consultant, ProPharma Group

"Great chance to connect with relevant people from the ecosystem"

– Head of Investment, Govt of Catalonia

"The event attracts a wide range of great people from across the industry. It is a fantastic networking opportunity"

– Senior Scientist, Rinri Therapeutics

Join us in London | 19-20 March 2024

Early bird expires this week
From £195 offer closes 03 November

Get Involved with the Advanced Therapies Congress

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

To speak

Ila Dickinson
ila.dickinson@terrapinn.com
+44 207 092 1150